Archive for September 2017

Science and Innovation Audit published – Medical Technologies in the Leeds City Region

Science and Innovation Audit published – Medical Technologies in the Leeds City Region

Government, industry and the NHS needs to invest between £200 million and £250 million in the Leeds City Region’s medical technology sector over the next five years, to enable it to exploit opportunities in the global health market – according to a new Science and Innovation audit.

Read More

Tissue Regenix acquires CellRight Technologies

CellRight Technologies, a US-based producer of regenerative osteoinductive bone scaffolds, has been acquired by Tissue Regenix Group plc (TRG). The deal was finalised on 9 August 2017. CellRight, brings a complementary regenerative technology to TRG which can be applied to allograft bone, following a process that removes DNA from tissue, so that malleable applications such […]

Read More

Growth in Vericel’s autologous cell therapy products reported

Vericel’s commercial product line consists of MACI (autologous cultured chondrocytes on porcine collagen membrane) for the repair of symptomatic, full-thickness cartilage defects of the knee in adults; Carticel (expanded autologous chondrocytes for the repair of articular cartilage injuries in patients with inadequate responses to prior arthroscopic or other surgical procedures) and Epicel (sheets of a […]

Read More
Creavo Medical Technologies closes £13.4m ($17m) funding round

Creavo Medical Technologies closes £13.4m ($17m) funding round

Creavo Medical Technologies, a Medical Technologies IKC partner, has announced that it has raised a further £13.4m ($17m) in equity funding. The round was oversubscribed and exceeded Creavo’s funding target, reflecting strong investor support and endorsement of Creavo’s strategy and team. Led by IP Group plc, the developer of intellectual property-based businesses and working with […]

Read More
Dr Pierre-Alexis Mouthuy to give keynote address at IKC & Regener8 annual conference

Dr Pierre-Alexis Mouthuy to give keynote address at IKC & Regener8 annual conference

Dr Pierre-Alexis Mouthuy will give the key note address at this years conference. The talk will be on ‘The translational journey of electrospun biomaterials designed to improve soft tissue repair.’ Dr Pierre-Alexis Mouthuy is a Senior Research Fellow at the Botnar Research Centre of the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences in Oxford. Dr […]

Read More
State of the Relationship Report 2017 highlights Leeds & DePuy Synthes partnership

State of the Relationship Report 2017 highlights Leeds & DePuy Synthes partnership

The fourth annual report on the State of the Relationship between universities, business and policy makers has highlighted the partnership between the University of Leeds and DePuy Synthes. The annual report provides strong examples of university business partnerships with updated metrics on progress in collaboration between universities, business and government in the UK monitor show […]

Read More

Med tech sector invited to voice opinion into Government audit

Professionals working in the med tech sector are being urged to complete an online survey to map out local research, innovation and infrastructure strengths across the UK.

The survey will contribute to a Science and Innovation Audit (SIA) on behalf of the Department for Business, Energy and Industry Strategy, to understand the Leeds City Region’s strengths and opportunities in Medical Technologies.

Read More
Call for poster submissions: Would you like to present at IKC & Regener8 Conference 2017?

Call for poster submissions: Would you like to present at IKC & Regener8 Conference 2017?

Poster submissions are invited from researchers, developers and innovators from the Regener8 and wider regenerative medicine community. Posters should reflect the core aim of Regener8 and the Medical Technologies IKC, which is to support the translation of university and industry-based research and development in regenerative devices (including enabling and companion technologies) into commercial products and […]

Read More
Heart device on trial that could save the NHS £200 million a year

Heart device on trial that could save the NHS £200 million a year

A new cardiac scanning device that could save the NHS £200 million a year is being trialled at four of the UK’s largest emergency departments (Bristol, Nottingham, Leicester and Sheffield). The British-made Vitalscan device, which has been developed by Creavo Medical Technologies and could revolutionise the way patients with chest pain are managed in emergency […]

Read More

Innovate UK-MoST funding for treatment of early osteoarthritis

A Proof of Concept Award funded as part of our partnership with Arthritis Research UK in 2015 has successfully secured a £2m Innovate UK-MoST grant, under UK-China Research and Innovation Bridges Competition 2015 scheme. The grant was awarded to continue the development of novel osteochondral scaffold technology for early intervention of osteoarthritis. Osteochondral scaffold technology, […]

Read More
back to top